Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

about

Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia Erlotinib and gefitinib, epidermal growth factor receptor kinase inhibitors, may treat non-cancer-related tumor necrosis factor-α mediated inflammatory diseases.

P2860

Q35069458-6D17FCDA-F88D-4939-941B-8F35F91EE9A9 Q42662426-AC4B833A-786F-4E05-B9B2-F3F8A2947AB8

P2860

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

Item

http://www.wikidata.org/entity/Q35606908

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

@ast

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

@en

type

Item

label

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

@ast

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

@en

prefLabel

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

@ast

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

@en

P1476

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

@en

P2093

Angel A Isidro

http://www.w3.org/2001/XMLSchema#string

Beatriz Pagán

http://www.w3.org/2001/XMLSchema#string

Caroline B Appleyard

http://www.w3.org/2001/XMLSchema#string

Domenico Coppola

http://www.w3.org/2001/XMLSchema#string

Jie Wu

http://www.w3.org/2001/XMLSchema#string

Myrella L Cruz

http://www.w3.org/2001/XMLSchema#string

Yuan Ren

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.

Understanding resistance to EGFR inhibitors-impact on future treatment strategies

EGFR signaling and drug discovery.

Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor.

EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer.

Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer

Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer.

Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.

AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

P304

4858-4866

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V17.I44.4858

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51881236

http://www.w3.org/2001/XMLSchema#string

P698

22171126

http://www.w3.org/2001/XMLSchema#string

P932

3235628

http://www.w3.org/2001/XMLSchema#string

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

about

P2860

P2860

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932